BusinessThird-Quarter Growth Lifts Charles River's 2026 EPS ForecastBy Helena WardNov 6, 2026, 6:27 AM UTC
BusinessPTC Therapeutics Authorizes Up to $500 Million in Share BuybacksBy Helena WardNov 3, 2026, 12:54 PM UTC
HealthBiopharma Survey Flags EU5 Launch Risks Under U.S. MFN PolicyBy Naomi CalderOct 28, 2026, 8:25 PM UTC
BusinessPharming Lifts 2026 Revenue Outlook Floor After Q3 Sales Rise 21%By Helena WardOct 22, 2026, 2:34 PM UTC
BusinessActinium Appoints Matt David as CFO and Principal Financial OfficerBy Helena WardOct 15, 2026, 1:45 PM UTC
